The company plans to establish centers throughout underserved communities as a means to provide more cost-effective treatment to the most vulnerable patients.
Dr. Tia Welsh oversees the delivery of clinical services, including program development and strategic planning throughout the organization.
The CEO of University Hospital discusses his efforts to change the culture at the Newark institution, maintain its role in the community and, of course, whether New Jerseyans can celebrate the holidays safely this year.
Molnupiravir, an investigational oral medicine, has had positive results in its clinical trial. If authorized, it could be the first treatment of its kind for COVID-19.
With the holidays approaching, and the CDC's flub on issuing guidance for a socially distanced holiday season, that was since recalled, one thing is clear: COVID-19 will continue to be on people’s minds through the end of the year, and it has businesses and public health experts wary.
The state's program currently has more than 119,000 patients supported by 1,306 doctors and 4,619 caregivers.
The debut of the region's only standalone birth center fell during National Midwifery Week, which occurs between Oct. 3 and Oct. 9, according to the American College of Nurse-Midwives.
As of Oct. 6, there were 986 hospitalizations—the last time the number was under 1,000 was on Aug. 23, when the state’s 71 acute-care hospitals logged 982 patients, according to the New Jersey Department of Health.
New syringe and needle lines at one of the company's Nebraska plants, completed as part of a public-private partnership with the Department of Health and Human Services' Assistant Secretary for Preparedness and Response, will provide the federal government with priority access to hundreds of millions of pieces of equipment.
With more than 25 years of experience in technology leadership working within the industry and with startups and multinational corporations, Kash Patel joins the system from Penn Medicine in Philadelphia.
A pair of accords stemming from Gov. Phil Murphy’s trade mission to the country in 2019 has spurred several collaborations among the life sciences industry, most recently between ABLE and BioNJ and the Institute for Life Science Entrepreneurship, respectively.
The Edison-based care-planning service is now part of Evolent, where it will report to that company's specialty management offering, New Century Health, and be consolidated into its Clinical Solutions segment, headquartered in Arlington, Va.